Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells. - Pilli T; Cantara S; Marzocchi C; Pacini F; Prabhakar BS; Castagna MG (Endocrine, 2020)